BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 25561782)

  • 1. Non invasive tools for the diagnosis of liver cirrhosis.
    Soresi M; Giannitrapani L; Cervello M; Licata A; Montalto G
    World J Gastroenterol; 2014 Dec; 20(48):18131-50. PubMed ID: 25561782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive diagnosis of liver fibrosis and cirrhosis.
    Lurie Y; Webb M; Cytter-Kuint R; Shteingart S; Lederkremer GZ
    World J Gastroenterol; 2015 Nov; 21(41):11567-83. PubMed ID: 26556987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive diagnosis of advanced fibrosis and cirrhosis.
    Sharma S; Khalili K; Nguyen GC
    World J Gastroenterol; 2014 Dec; 20(45):16820-30. PubMed ID: 25492996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound Shear Wave Elastography for Liver Disease. A Critical Appraisal of the Many Actors on the Stage.
    Piscaglia F; Salvatore V; Mulazzani L; Cantisani V; Schiavone C
    Ultraschall Med; 2016 Feb; 37(1):1-5. PubMed ID: 26871407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive assessment of liver fibrosis in chronic hepatitis B.
    Branchi F; Conti CB; Baccarin A; Lampertico P; Conte D; Fraquelli M
    World J Gastroenterol; 2014 Oct; 20(40):14568-80. PubMed ID: 25356021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of transient elastography, serum markers and clinical signs for the diagnosis of compensated cirrhosis.
    Malik R; Lai M; Sadiq A; Farnan R; Mehta S; Nasser I; Challies T; Schuppan D; Afdhal N
    J Gastroenterol Hepatol; 2010 Sep; 25(9):1562-8. PubMed ID: 20796156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive assessment of liver fibrosis and prognosis.
    Hagan M; Asrani SK; Talwalkar J
    Expert Rev Gastroenterol Hepatol; 2015; 9(10):1251-60. PubMed ID: 26377444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive assessment of liver fibrosis and prognosis: an update on serum and elastography markers.
    Agbim U; Asrani SK
    Expert Rev Gastroenterol Hepatol; 2019 Apr; 13(4):361-374. PubMed ID: 30791772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan®.
    Cassinotto C; Lapuyade B; Mouries A; Hiriart JB; Vergniol J; Gaye D; Castain C; Le Bail B; Chermak F; Foucher J; Laurent F; Montaudon M; De Ledinghen V
    J Hepatol; 2014 Sep; 61(3):550-7. PubMed ID: 24815876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of inflammation and fibrosis in non-alcoholic fatty liver disease by imaging-based techniques.
    Cobbold JF; Patel D; Taylor-Robinson SD
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1281-92. PubMed ID: 22432836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive diagnosis of hepatitis B virus-related cirrhosis.
    Lee S; Kim DY
    World J Gastroenterol; 2014 Jan; 20(2):445-59. PubMed ID: 24574713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohort.
    Munsterman ID; Duijnhouwer AL; Kendall TJ; Bronkhorst CM; Ronot M; van Wettere M; van Dijk APJ; Drenth JPH; Tjwa ETTL;
    Eur Heart J; 2019 Apr; 40(13):1057-1068. PubMed ID: 30346512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness.
    Stasi C; Milani S
    World J Gastroenterol; 2016 Jan; 22(4):1711-20. PubMed ID: 26819535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.
    Stål P
    World J Gastroenterol; 2015 Oct; 21(39):11077-87. PubMed ID: 26494963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved fibrosis staging by elastometry and blood test in chronic hepatitis C.
    Calès P; Boursier J; Ducancelle A; Oberti F; Hubert I; Hunault G; de Lédinghen V; Zarski JP; Salmon D; Lunel F;
    Liver Int; 2014 Jul; 34(6):907-17. PubMed ID: 24102852
    [TBL] [Abstract][Full Text] [Related]  

  • 16.  Noninvasive markers of fibrosis: key concepts for improving accuracy in daily clinical practice.
    Duarte-Rojo A; Altamirano JT; Feld JJ
    Ann Hepatol; 2012; 11(4):426-39. PubMed ID: 22700624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive diagnosis of liver fibrosis: utility of data mining of both ultrasound elastography and serological findings to construct a decision tree.
    Yada N; Kudo M; Kawada N; Sato S; Osaki Y; Ishikawa A; Miyoshi H; Sakamoto M; Kage M; Nakashima O; Tonomura A
    Oncology; 2014; 87 Suppl 1():63-72. PubMed ID: 25427735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving strategies for liver fibrosis staging: Non-invasive assessment.
    Stasi C; Milani S
    World J Gastroenterol; 2017 Jan; 23(2):191-196. PubMed ID: 28127192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New non-invasive tool for assessment of liver fibrosis: transient elastography].
    Horváth G
    Orv Hetil; 2011 May; 152(22):860-5. PubMed ID: 21565752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doppler ultrasonography combined with transient elastography improves the non-invasive assessment of fibrosis in patients with chronic liver diseases.
    Alempijevic T; Zec S; Nikolic V; Veljkovic A; Stojanovic Z; Matovic V; Milosavljevic T
    Med Ultrason; 2017 Jan; 19(1):7-15. PubMed ID: 28180191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.